Szczepionka Przeciwgruźlicza Bcg 10

Szczepionka Przeciwgruźlicza Bcg 10 contains live BCG bacilli (Bacillus Calmette-Guerin) for tuberculosis prevention. Administered intradermally, it helps build immunity against mycobacterium tuberculosis. Suitable for high-risk groups and travelers to endemic regions. Short-term protection may require booster doses.

Szczepionka Przeciwgruźlicza Bcg 10 is used to prevent tuberculosis (TB) by stimulating the immune system to recognize and fight Mycobacterium tuberculosis. It is commonly recommended for infants in high-prevalence areas, healthcare workers, and individuals exposed to active TB cases. The vaccine does not treat existing TB but helps reduce infection risk in vulnerable populations.

After administration, the immune system responds by developing antibodies against TB bacteria. Local skin reactions at the injection site, such as redness or swelling, are common and indicate the vaccine is working. Mild fever or fatigue may occur shortly after vaccination but typically resolves quickly.

Store Szczepionka Przeciwgruźlicza Bcg 10 refrigerated between 2°C and 8°C to maintain potency. Avoid freezing or exposure to direct sunlight. Use only sterile equipment for intradermal injection to prevent infection. Discard any unused vaccine after the recommended timeframe to ensure safety.

No significant drug interactions are reported with Szczepionka Przeciwgruźlicza Bcg 10. However, immunosuppressive therapies or recent live vaccines may reduce its effectiveness. Consult a healthcare provider before administration if undergoing chemotherapy or steroid treatment. Alcohol does not directly interact but may impair immune response.